{
    "2019-07-01": [
        [
            {
                "time": "2019-01-02",
                "original_text": "Look at NVO’s Spending and Earnings in Fiscal 2019",
                "features": {
                    "keywords": [
                        "NVO",
                        "Spending",
                        "Earnings",
                        "Fiscal 2019"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-02",
                "original_text": "How NVO’s Revenues Are Trending in Fiscal 2019",
                "features": {
                    "keywords": [
                        "NVO",
                        "Revenues",
                        "Trending",
                        "Fiscal 2019"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-02",
                "original_text": "What Analysts Recommend for GlaxoSmithKline and Novo Nordisk",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommend",
                        "GlaxoSmithKline",
                        "Novo Nordisk"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-02",
                "original_text": "Market Morning: OPEC Cuts, Trump & Xi Ceasefire, Apple Goes to China, Deutsche Bank Hiring",
                "features": {
                    "keywords": [
                        "OPEC Cuts",
                        "Trump",
                        "Xi",
                        "Ceasefire",
                        "Apple",
                        "China",
                        "Deutsche Bank",
                        "Hiring"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy",
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}